Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Race Oncology Ltd. ( (AU:RAC) ) has provided an update.
Race Oncology Ltd has announced the quotation of 594,081 new fully paid ordinary shares on the Australian Securities Exchange (ASX), effective from October 16, 2025. This move is part of the company’s strategy to enhance its capital structure, potentially improving its market positioning and providing additional resources for ongoing and future projects in cancer treatment development.
More about Race Oncology Ltd.
Race Oncology Ltd is a company operating in the biotechnology industry, focusing on the development and commercialization of cancer therapies. The company’s primary product offerings include innovative treatments aimed at addressing unmet medical needs in oncology.
Average Trading Volume: 420,849
Technical Sentiment Signal: Buy
Current Market Cap: A$800.5M
For detailed information about RAC stock, go to TipRanks’ Stock Analysis page.